Kristopher Nazor

Kristopher Nazor has a diverse work experience spanning several companies and positions. Kristopher is currently serving as the Chief Executive Officer at Proteintech Genomics since April 2022. Prior to this, they held the position of Chief Business Officer at Spatial Genomics, Inc. from February 2021 to March 2022. Before that, they worked as the Proteogenomics Business Head at BioLegend from January 2018 to February 2021.

Kristopher also co-founded and served as the Chief Science Officer at MYi Diagnostics and Discovery from March 2015 to October 2017. Kristopher started their career as a Graduate Student at The Scripps Research Institute, where they worked from July 2008 to March 2015. Additionally, they held positions as a Dennis Weatherstone Fellow at Autism Speaks from 2011 to 2013 and as a Pre-Doctoral Fellow at the California Institute for Regenerative Medicine from 2009 to 2011. Kristopher's early experience includes working as an SRA II at UCSF from 2005 to 2008.

Kristopher Nazor completed their Bachelor of Science degree in Biochemistry, Cellular and Molecular Biology from the University of Tennessee, Knoxville, from the year 2000 to 2005. Kristopher then pursued further education and obtained their Ph.D. in Bioinformatics and Stem Cell Biology from Scripps Research between the years 2008 and 2015.